BioLargo Reports Revenue Decline and Increased Losses

BioLargo ( (BLGO) ) has released its Q1 earnings. Here is a breakdown of the information BioLargo presented to its investors.

BioLargo, Inc. is a company that invents, develops, and commercializes innovative platform technologies aimed at solving environmental problems, primarily in the sectors of water treatment, air quality control, and environmental remediation. The company is known for its disruptive technologies and strategic partnerships.

In its latest earnings report for the quarter ended March 31, 2025, BioLargo reported a decline in revenue compared to the previous year, with total revenue dropping from $4.76 million to $3.27 million. The company also reported a net loss of $1.92 million, which is a significant increase from the $775,000 loss reported in the same quarter of the previous year.

Key financial metrics from the report indicate that BioLargo’s product revenue decreased significantly, while service revenue saw an increase. The company’s gross profit also declined, and operating expenses rose, contributing to a larger operating loss. Additionally, the company experienced an increase in accounts receivable, which impacted its cash flow.

Despite the financial challenges, BioLargo continues to pursue strategic initiatives, including ongoing research and development efforts supported by grants, and maintaining its focus on expanding its market presence through partnerships and licensing agreements.

Looking ahead, BioLargo’s management remains focused on increasing revenues and securing additional investment capital to support its operations and growth strategies. The company acknowledges the need for further financial resources to sustain its current level of operations and to continue developing its innovative technologies.